Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-16 | IONIS PHARMACEUTICALS INC | Baroldi Joseph
(EVP, Chief Business Officer) |
S | Common Stock | D | 4006 | $41.60 - $41.60 | $166,640 |
| 2024-04-15 | IONIS PHARMACEUTICALS INC | Baroldi Joseph
(EVP, Chief Business Officer) |
M | Common Stock | A | 10838 | $0.00 - $0.00 | $0 |
| 2024-04-16 | IONIS PHARMACEUTICALS INC | Birchler Brian
(EVP, Corp and Development Ops) |
S | Common Stock | D | 905 | $41.66 - $41.66 | $37,698 |
| 2024-04-15 | IONIS PHARMACEUTICALS INC | Birchler Brian
(EVP, Corp and Development Ops) |
M | Common Stock | A | 1875 | $0.00 - $0.00 | $0 |
| 2024-02-29 | IONIS PHARMACEUTICALS INC | Swayze Eric
(Officer Level 14) |
J | Common Stock | A | 605 | $34.42 - $34.42 | $20,827 |
| 2024-02-29 | IONIS PHARMACEUTICALS INC | Monia Brett P
(CEO Level 15) |
J | Common Stock | A | 538 | $34.42 - $34.42 | $18,520 |
| 2024-02-29 | IONIS PHARMACEUTICALS INC | Geary Richard S
(Officer Level 14) |
J | Common Stock | A | 604 | $34.42 - $34.42 | $20,792 |
| 2024-02-29 | IONIS PHARMACEUTICALS INC | Birchler Brian
(Vice President Level 14) |
J | Common Stock | A | 604 | $34.42 - $34.42 | $20,792 |
| 2024-02-29 | IONIS PHARMACEUTICALS INC | BENNETT C FRANK
(Officer Level 14) |
J | Common Stock | A | 383 | $34.42 - $34.42 | $13,184 |
| 2024-02-16 | IONIS PHARMACEUTICALS INC | Monia Brett P
(Chief Executive Officer) |
S | Common Stock | D | 387 | $44.49 - $44.49 | $17,218 |
| 2024-01-31 | IONIS PHARMACEUTICALS INC | Swayze Eric
(EVP Research) |
S | Common Stock | D | 12680 | $49.56 - $52.00 | $654,709 |
| 2024-02-01 | IONIS PHARMACEUTICALS INC | Swayze Eric
(EVP Research) |
A | Common Stock | A | 3715 | $0.00 - $0.00 | $0 |
| 2024-02-02 | IONIS PHARMACEUTICALS INC | Schneider Eugene
(EVP, Chf Clinical Develop Ofcr) |
S | Common Stock | D | 2071 | $49.59 - $49.59 | $102,700 |
| 2024-02-01 | IONIS PHARMACEUTICALS INC | Schneider Eugene
(EVP, Chf Clinical Develop Ofcr) |
A | Common Stock | A | 4033 | $0.00 - $0.00 | $0 |
| 2024-02-02 | IONIS PHARMACEUTICALS INC | O'NEIL PATRICK R.
(EVP CLO & General Counsel) |
S | Common Stock | D | 1961 | $49.67 - $49.67 | $97,410 |
| 2024-02-01 | IONIS PHARMACEUTICALS INC | O'NEIL PATRICK R.
(EVP CLO & General Counsel) |
A | Common Stock | A | 3820 | $0.00 - $0.00 | $0 |
| 2024-02-02 | IONIS PHARMACEUTICALS INC | Monia Brett P
(Chief Executive Officer) |
S | Common Stock | D | 23501 | $49.37 - $49.37 | $1,160,303 |
| 2024-02-01 | IONIS PHARMACEUTICALS INC | Monia Brett P
(Chief Executive Officer) |
A | Common Stock | A | 45788 | $0.00 - $0.00 | $0 |
| 2024-02-02 | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L
(EVP, Finance & CFO) |
S | Common Stock | D | 2125 | $49.54 - $49.54 | $105,272 |
| 2024-02-01 | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L
(EVP, Finance & CFO) |
A | Common Stock | A | 4140 | $0.00 - $0.00 | $0 |
| 2024-02-02 | IONIS PHARMACEUTICALS INC | Geary Richard S
(EVP, Chief Development Officer) |
S | Common Stock | D | 1961 | $50.04 - $50.04 | $98,134 |
| 2024-02-01 | IONIS PHARMACEUTICALS INC | Geary Richard S
(EVP, Chief Development Officer) |
A | Common Stock | A | 3820 | $0.00 - $0.00 | $0 |
| 2024-02-02 | IONIS PHARMACEUTICALS INC | Cadoret-Manier On...
(EVP, Chf GL Pdt Str & Oper Ofc) |
S | Common Stock | D | 2125 | $49.60 - $49.60 | $105,404 |
| 2024-02-01 | IONIS PHARMACEUTICALS INC | Cadoret-Manier On...
(EVP, Chf GL Pdt Str & Oper Ofc) |
A | Common Stock | A | 4140 | $0.00 - $0.00 | $0 |
| 2024-02-02 | IONIS PHARMACEUTICALS INC | BENNETT C FRANK
(EVP, Chief Scientific Officer) |
S | Common Stock | D | 1853 | $49.52 - $49.52 | $91,752 |
| 2024-02-01 | IONIS PHARMACEUTICALS INC | BENNETT C FRANK
(EVP, Chief Scientific Officer) |
A | Common Stock | A | 3609 | $0.00 - $0.00 | $0 |
| 2024-01-25 | IONIS PHARMACEUTICALS INC | Monia Brett P
(Chief Executive Officer) |
S | Common Stock | D | 2285 | $51.75 - $51.75 | $118,248 |
| 2024-01-25 | IONIS PHARMACEUTICALS INC | O'NEIL PATRICK R.
(EVP CLO & General Counsel) |
S | Common Stock | D | 6450 | $51.75 - $51.75 | $333,787 |
| 2024-01-17 | IONIS PHARMACEUTICALS INC | Cadoret-Manier On...
(EVP, Chf GL Pdt Str & Oper Ofc) |
S | Common Stock | D | 5564 | $50.42 - $50.42 | $280,520 |
| 2024-01-16 | IONIS PHARMACEUTICALS INC | Cadoret-Manier On...
(EVP, Chf GL Pdt Str & Oper Ofc) |
M | Common Stock | A | 15062 | $0.00 - $0.00 | $0 |
| 2024-01-17 | IONIS PHARMACEUTICALS INC | O'NEIL PATRICK R.
(EVP CLO & General Counsel) |
S | Common Stock | D | 7744 | $50.42 - $50.42 | $390,429 |
| 2024-01-16 | IONIS PHARMACEUTICALS INC | O'NEIL PATRICK R.
(EVP CLO & General Counsel) |
M | Common Stock | A | 20641 | $0.00 - $0.00 | $0 |
| 2024-01-17 | IONIS PHARMACEUTICALS INC | Birchler Brian
(EVP, Corp and Development Ops) |
S | Common Stock | D | 4497 | $50.42 - $50.42 | $226,725 |
| 2024-01-16 | IONIS PHARMACEUTICALS INC | Birchler Brian
(EVP, Corp and Development Ops) |
M | Common Stock | A | 12080 | $0.00 - $0.00 | $0 |
| 2024-01-17 | IONIS PHARMACEUTICALS INC | Swayze Eric
(EVP Research) |
S | Common Stock | D | 6305 | $50.42 - $50.42 | $317,878 |
| 2024-01-16 | IONIS PHARMACEUTICALS INC | Swayze Eric
(EVP Research) |
M | Common Stock | A | 17090 | $0.00 - $0.00 | $0 |
| 2024-01-17 | IONIS PHARMACEUTICALS INC | Schneider Eugene
(EVP, Chf Clinical Develop Ofcr) |
S | Common Stock | D | 5482 | $50.42 - $50.42 | $276,385 |
| 2024-01-16 | IONIS PHARMACEUTICALS INC | Schneider Eugene
(EVP, Chf Clinical Develop Ofcr) |
M | Common Stock | A | 15162 | $0.00 - $0.00 | $0 |
| 2024-01-17 | IONIS PHARMACEUTICALS INC | Monia Brett P
(Chief Executive Officer) |
S | Common Stock | D | 32059 | $50.42 - $50.42 | $1,616,318 |
| 2024-01-16 | IONIS PHARMACEUTICALS INC | Monia Brett P
(Chief Executive Officer) |
M | Common Stock | A | 68084 | $0.00 - $0.00 | $0 |
| 2024-01-17 | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L
(EVP, Finance & CFO) |
S | Common Stock | D | 8683 | $50.42 - $50.42 | $437,770 |
| 2024-01-16 | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L
(EVP, Finance & CFO) |
M | Common Stock | A | 22487 | $0.00 - $0.00 | $0 |
| 2024-01-17 | IONIS PHARMACEUTICALS INC | Geary Richard S
(EVP, Chief Development Officer) |
S | Common Stock | D | 7338 | $50.42 - $50.42 | $369,959 |
| 2024-01-16 | IONIS PHARMACEUTICALS INC | Geary Richard S
(EVP, Chief Development Officer) |
M | Common Stock | A | 19852 | $0.00 - $0.00 | $0 |
| 2024-01-17 | IONIS PHARMACEUTICALS INC | BENNETT C FRANK
(EVP, Chief Scientific Officer) |
S | Common Stock | D | 6745 | $50.42 - $50.42 | $340,062 |
| 2024-01-16 | IONIS PHARMACEUTICALS INC | BENNETT C FRANK
(EVP, Chief Scientific Officer) |
M | Common Stock | A | 18314 | $0.00 - $0.00 | $0 |
| 2024-01-17 | IONIS PHARMACEUTICALS INC | Baroldi Joseph
(EVP, Chief Business Officer) |
S | Common Stock | D | 2024 | $50.42 - $50.42 | $102,043 |
| 2024-01-16 | IONIS PHARMACEUTICALS INC | Baroldi Joseph
(EVP, Chief Business Officer) |
M | Common Stock | A | 5041 | $0.00 - $0.00 | $0 |
| 2024-01-12 | IONIS PHARMACEUTICALS INC | Schneider Eugene
(EVP, Chf Clinical Develop Ofcr) |
S | Common Stock | D | 8000 | $53.50 - $53.50 | $427,999 |
| 2024-01-12 | IONIS PHARMACEUTICALS INC | Schneider Eugene
(EVP, Chf Clinical Develop Ofcr) |
M | Common Stock | A | 8000 | $32.60 - $32.60 | $260,800 |
| 2023-12-28 | IONIS PHARMACEUTICALS INC | Swayze Eric
(EVP Research) |
S | Common Stock | D | 27100 | $50.19 - $50.19 | $1,360,081 |
| 2023-12-28 | IONIS PHARMACEUTICALS INC | Swayze Eric
(EVP Research) |
M | Common Stock | A | 27100 | $47.34 - $47.34 | $1,282,914 |
| 2023-12-28 | IONIS PHARMACEUTICALS INC | HOUGEN ELIZABETH L
(EVP, Finance & CFO) |
F | Common Stock | D | 43798 | $50.50 - $50.50 | $2,211,799 |
| 2023-12-14 | IONIS PHARMACEUTICALS INC | BENNETT C FRANK
(EVP, Chief Scientific Officer) |
S | Common Stock | D | 22612 | $49.21 - $50.19 | $1,121,194 |
| 2023-12-14 | IONIS PHARMACEUTICALS INC | BENNETT C FRANK
(EVP, Chief Scientific Officer) |
M | Common Stock | A | 22612 | $47.34 - $47.34 | $1,070,451 |
| 2023-11-15 | IONIS PHARMACEUTICALS INC | KLEIN JOSEPH III
(Director) |
S | Common Stock | D | 2000 | $50.00 - $50.00 | $100,000 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |